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developing allergic airways disease and showed a marked
decrease in pathophysiology, including lung function and airway
eosinophilia induced by Alternaria. Alternaria is a potent
inducer of cellular stress and the unfolded protein response, and
ORMDL3 was found to play a critical role in driving the
activating transcription factor 6–mediated arm of this response
through Xbp1 and downstream activation of the endoplasmic
reticulum–associated degradation pathway. In addition,
ORMDL3 mediated uric acid release, another marker of
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Abbreviations used
AAD: Allergic airways disease
AAV: Adeno-associated viral vector
AHR: Airway hyperreactivity
ATF: Activating transcription factor
BALF: Bronchoalveolar lavage fluid
EGFP: Enhanced green fluorescent protein
ER: Endoplasmic reticulum
GWAS: Genome-wide association study
IRE: Inositol requiring ER-to-nucleus signal kinase
KO: Knockout
ORMDL: ORM-1 like protein
PERK: Double-stranded RNA-activated protein kinase (PKR)-
like endoplasmic reticulum kinase
SERCA2b: Sarco-endoplasmic reticulum Ca21 ATPase 2b
SNP: Single nucleotide polymorphism
UK: United Kingdom
UPR: Unfolded protein response
WT: Wild-type
Xbp1: X-box binding protein 1
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in reinstatement of susceptibility to fungal allergen–induced
allergic airways disease.
Conclusions: This study demonstrates that ORMDL3, an asthma
susceptibility gene identified by genome-wide association
studies, contributes to key pathways that promote changes in
airway physiology during allergic immune responses. (J Allergy
Clin Immunol 2017;139:1496-507.)
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Asthma encompasses a range of pulmonary disease phenotypes
commonly defined by a type 2 inflammatory response to airborne
allergen concomitant with airway hyperresponsiveness (AHR).1
Although the underlying etiologies for asthma are incompletely un-
derstood, it is recognized that the epithelial barrier plays a central
role in asthma pathogenesis and that genetic predisposition can
bepivotal for asthmadevelopment.2A pioneering genome-wide as-
sociation study (GWAS) identified single nucleotide polymor-
phisms (SNPs) on chromosome 17q21 that were strongly linked
to asthma.3 The same SNPs were also found to be associated with
increased expression of transcripts of the ORM-1 like protein 3
(ORMDL3) gene.3 However, the functional role of ORMDL3 in
asthma has not as yet been fully elucidated, and it is not known
how this molecule contributes to disease pathophysiology.
ORMDL3 is expressed in various tissues, including the lung
where it is predominantly localized to airway epithelial cells in
response toAlternaria or ovalbumin challenge.4,5 It is a transmem-
brane protein located in the endoplasmic reticulum (ER)4 where
physiologically it acts to negatively regulate sphingolipid synthe-
sis.6 Intriguingly, it has been demonstrated that reduction of sphin-
golipid synthesis with pharmacological compounds increases
AHR in mice and human bronchial tissue.7 However, in a murine
model of house dustmite–induced allergic airways disease (AAD),
elevated levels of ORMDL3 in response to allergen correlate with
increased ceramide production.8 Previous studies with mice uni-
versally overexpressing ORMDL3 have demonstrated that these
mice spontaneously develop increased AHR and airway remodel-
ing, which precedes elevated type 2 pulmonary inflammation.9
ER stress can be induced on perturbation of luminal Ca21 levels
within theER, consequently decreasing the efficiencyof correct pro-
tein folding.10 Accumulation of nascent or misfolded protein in the
ER lumen leads to activation of the unfolded protein response
(UPR).11,12 Available data indicate that ORMDL3 modulates the
UPR although the pathways involved may be tissue specific. Bone
marrow–derived macrophages from Ormdl3 transgenic mice have
increased activation of the activating transcription factor (ATF) 6
pathway of the UPR,9 similar to previous observations using lung
epithelial A549 cells transfected with ORMDL3 in vitro.5 In these
systems, expression of ORMDL3 is positively correlated with
expression of sarco-endoplasmic reticulum Ca21 ATPase 2b (SER-
CA2b), a downstream target of theATF6pathway.13 InHEK293and
Jurkat cells transfected with Ormdl3, the data illustrate that
ORMDL3 binds to and inhibits SERCA, thereby impeding entry
of cytosolic Ca21 into the ER lumen and initiating the UPR.14 How-
ever, within this experimental setting, themain impact of ORMDL3
is on the double-stranded RNA-activated protein kinase (PKR)-like
endoplasmic reticulum kinase (PERK)/eIF2a arm of the UPR.
In the present study, Ormdl3-deficient mice were generated to
investigate the role of ORMDL3 in determining the pulmonaryresponse to allergen. In addition, we have reconstituted ORMDL3
specifically in the bronchial epithelium of these knockout (KO)
mice to ascertain the specific contribution of epithelial ORMDL3.
These mice reveal that ORMDL3 is pivotal in the generation of
fungal allergen–induced AHR via modulation of cellular stress
pathways. Our data reinforce the findings of asthma GWAS,
placing ORMDL3 as an important mediator in the development
of allergen-induced AHR.
METHODS
Generation of Ormdl3 KO mice
Two separateOrmdl3 alleles were used in the study. The first was generated
by Dr. Y Zhang at the Mary Lyon Centre, MRC Harwell, and the second was
made and kindly donated by Merck Research Laboratories. Both constructs
contained LoxP sites flanking exons 1 to 4 ofOrmdl3, the translation initiation
site of the gene being contained within exon 2. Initially, conditional alleles
were generated by Flp-mediated removal of selection cassettes. The targeting
strategies for both lines were similar; however, the Merck construct contained
dual Neo and Puro selection cassettes, whereas the Harwell allele contained a
single Neo selection cassette (see Fig E1 in this article’s Online Repository at
www.jacionline.org). At Merck, targeting constructs were micro-injected into
embryonic stem cells from C57/Bl6NTac mice and complete Ormdl3 KOs
were subsequently generated by Cre-mediated recombination, using
globally expressed Cre-driver mouse lines.15 At Harwell, targeting constructs
were micro-injected into ES cells fromR1 129 ES cells andOrmdl3KOs were
subsequently generated byCre-mediated recombination, using Tg(ACTB-cre)
3Mrt mice (Infrafrontier; accession no. EM:06107). These Ormdl3 KO mice
were subsequently crossed on to a C57BL/6J background (10 generations).
A similar response to allergen was observed in both strains. The MERCK
Ormdl3 KO line (Ormdl3 KOMer) was used for experiments where mice
were treated as adults. Experiments which required in-house breeding at
Imperial College were performed using the Ormdl3 KO line generated by
Dr Y Zhang (Ormdl3 KOHar).Construction of enhanced green fluorescent protein
and Ormdl3-enhanced green fluorescent protein
adeno-associated viral vectors
AnOrmdl3-enhancedgreen fluorescent protein (EGFP) (N-terminal tag) gene
fusion was constructed and cloned into plasmid pZac2.1 under control of the
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FIG 1. Ormdl3 KOMer mice are protected from developing Alternaria-
induced AHR. A, Expression of Ormdl1 to Ormdl3 in lungs of naive WT and
KO mice by quantitative PCR. B, Experimental plan (C-H). Lung function
measured using the FlexiVent system. Dose-response curve to methacho-
line showing (Fig 1, C) airway resistance, (Fig 1, E) airway elastance, and
(Fig 1, G) airway compliance. Airway resistance (Fig 1, D), airway elastance
(Fig 1, F), and airway compliance (Fig 1, H) at 200 mg/mL methacholine. I,
Concentration-response curveof tracheas toward increasing concentrations
ofmethacholine. J, EC50 values of contraction responses.Alt,Alternaria;BL,
baseline; i.n., intranasal; Data were collected from 2 individually performed
experiments. N 5 8-12 mice per group. Box and whisker plots depict the
median and interquartile range and minimum and maximum values.
*P < .05, **P < .005, and ***P < .0005.
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1498 L€OSER ET ALubiquitous cytomegalovirus promoter. Adeno-associated viral vectors (AAVs)
were produced by Penn Vector Core (University of Pennsylvania, Pa). On day
5 of life, neonatal mice were intranasally administered 13 1011 genome copies
of either AAV EGFP (control vector) or AAV Ormdl3-EGFP (AAV Ormdl3)
with 50 mU neuraminidase (Sigma-Aldrich, Dorset, United Kingdom [UK]) in
PBS. At age 8 weeks, mice received either 10 mg Alternaria alternata extract
(Greer Laboratories, Lenoir, NC) or PBS via intranasal instillation, 3 times per
week for 5 weeks. Mice were killed 18 hours postfinal Alternaria instillation.Induction of AAD
Ten- to 12-week-old male wild-type (WT) and Ormdl3 KOMer mice were
bred at Taconic Biosciences (Germantown, New York, NY). WT and Ormdl3
KOHarmice (Harwell, UK)were bred at Imperial, and neonatalmicewere used
for overexpression studies. All mice were housed in specific pathogen-free
conditions and given food and water ad libitum. Mice were exposed to
20 mg of purified Alternaria alternata extract (Greer Laboratories) (in 25mL
PBS) intranasally 3 d/wk for 5 weeks. All procedures were conducted in
accordance with the Animals (Scientific Procedures) Act 1986.
Assessment of airway function
AHR in response to increasing doses of methacholine (10-200 mg/mL;
Sigma-Aldrich) was measured as previously described,16 using the Flexivent
system (Scireq, Montreal, Quebec, Canada).In vitro measurement of airway smooth muscle
function
Tracheal tissue was harvested from WT or Ormdl3 KOMer mice. Agonist
concentration-response curves to methacholine or vehicle were subsequently
fitted by least-squares, nonlinear regression based on the Hill equation (Prism
5, GraphPad Software Inc, La Jolla, Calif). Mean EC50 values were calculated
by averaging data from interpolation of response curves constructed for each
individual tissue within a data set.
Statistical analysis
All datawere analyzed usingGraph Pad Prism 6 (GraphPad Software). Box
and whisker plots depict the median and interquartile range and minimum and
maximum values. Line graphs and bar charts are expressed as mean 6 SEM,
and data were analyzed using nonparametric Mann Whitney U tests with sig-
nificance defined as *P < .05, **P < .01, and ***P < .001.
Methods for in vitro assessment of airway smooth muscle function, quan-
titative PCR, RT-PCR, immunofluorescence, isolation and sorting of epithelial
and CD451 cells, flow cytometry, Western blotting, and mediator analysis are
described in the Methods section in this article’s Online Repository at www.
jacionline.org.RESULTS
Ormdl3 deficiency protects mice from developing
fungal allergen–induced AHR
ORMDL3 is ubiquitously expressed in adult and fetal
tissues including the lung3,4 and also in leukocytes.5,17 To
assess the impact of ORMDL3 on induction of AAD, we
generated global Ormdl3 KO mice. We report that mice lacking
Ormdl3 had no baseline phenotype, appearing healthy and
fertile with no alterations in the lung architecture or immune
changes at homeostasis compared with WT littermate C57bl/6
mice. Despite deletion of Ormdl3, there was no compensatory
upregulation of the closely related genes Ormdl1 and Ormdl2 in
the lungs of the KO mice as determined by quantitative PCR
(Fig 1, A).
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FIG 2. Analysis of Alternaria-induced AAD in WT andOrmdl3 KOMer mice. A, Lung total cell counts. B, Alter-
naria-induced pulmonary inflammation in tissue sections (H&E staining). C, BALF total cell counts.D, Eosin-
ophils expressed as the percentage SiglecF1 CD11c2 CD682 lung cells. E, Total IgE concentration. F,
Alternaria-specific IgE concentration. Representative photomicrographs are shown. Original magnification
320. Alt, Alternaria; H&E, hematoxylin & eosin. Data were collected from 2 individually performed
experiments. N 5 8-16 mice per group. Box and whisker plots depict the median and interquartile range
and minimum and maximum values. *P < .05, **P < .005, and ***P < .0005.
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Ormdl3 mRNA expression has been shown to be induced in
bronchial epithelial cells.5 To investigate the functional role of
ORMDL3 during the development of asthma, we therefore
developed a chronic Alternaria-induced AAD model (Fig 1, B).
In WT mice, Alternaria induced the hallmark features of asthma,
including AHR (Fig 1, C-H), lung and airway inflammation, as
well as eosinophilia (Fig 2, A-D). IgE concentrations were also
augmented following allergen challenge (Fig 2, E and F). We
also observed an increase in pulmonary IL-131 T cells (TH2)
and type 2 innate lymphoid cells, enumerated by flow cytometry
(Fig 3, A and B). Concomitant with the elevated AHR, pulmonary
levels of IL-13 were increased (Fig 3, C).
Mice deficient inOrmdl3were protected from the development
of Alternaria-induced airway resistance and elastance (Fig 1,
C-F) and allergen-induced decreases in airway compliance
(Fig 1,G andH). Changes in airway resistance result from altered
contractility of the smooth muscle surrounding the airways.
Therefore, we chose to investigate whether intrinsic defects in
smooth muscle cells could account for differences in lung
function between WT and Ormdl3 KOMer mice. Tracheal rings
from naive mice were isolated and the contraction responses
toward increasing methacholine concentrations were compared
(Fig 1, I). The methacholine EC50 valuewas significantly reduced
in mice lacking ORMDL3 (Fig 1, J), indicating that ORMDL3
plays a role in airway smooth muscle contractility.To further dissect the mechanisms that may account for the
reduced Alternaria-induced AHR in Ormdl3 KOMer mice, we
profiled the inflammatory cells and mediators present in the
lung. Alternaria induced cell recruitment to the lung (Fig 2, A
and B) and bronchoalveolar lavage (Fig 2, C) was not affected
by pulmonary expression of ORMDL3, although the proportion
of eosinophils was minimally but statistically significantly
reduced (38% vs 28% SiglecF1CD11c2CD682 cells of total
cells) in allergen-exposed Ormdl3 KO miceMer (Fig 2, D). Class
switching to the allergy-associated IgE was unaffected by the
loss of ORMDL3 (Fig 2,E), although therewas amodest decrease
in the levels of Alternaria-specific IgE (0.78OD vs 0.61OD)
(Fig 2, F) in Ormdl3 KO miceMer.
The number of TH2 (CD4
1IL-131) cells and type 2 innate
lymphoid cells (LinnegICOS1IL-131) recruited to the lung
(Fig 3, A and B) and bronchoalveolar lavage (data not shown)
was not different between Ormdl3-sufficient and Ormdl3-defi-
cient mice. Despite the reduction in AHR in mice lacking
ORMDL3, these mice responded to Alternaria exposure with
increased levels of pulmonary TH2 cytokines including IL-13,
IL-4, and IL-5 in the lung (Fig 3, C-E). Concentrations of these
cytokines were less than those observed in WT mice, but the
reduction was not statistically significant. A small but signifi-
cant increase in baseline levels of IL-5 was also noted (204
pg/mL vs 253 pg/mL) in the lung tissue (Fig 3, E). Similarly,
Alternaria-induced increases in the levels of the pulmonary
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FIG 3. ORMDL3 does not influence Alternaria-induced type 2 inflammation or mediators. A, Pulmonary TH2
cells (IL-131 CD41 CD31). B, ILC2 cells (IL-131 ICOS1 CD451 lineage2 cells). IL-13 (C), IL-4 (D), IL-5 (E), and
IL-33 (F) cytokine levels in lung tissue determined by ELISA. Alt, Alternaria. Data were collected from 2 indi-
vidually performed experiments. N 5 8-16 mice per group. Box and whisker plots depict the median and
interquartile range and minimum and maximum values. ILC2, Type 2 innate lymphoid cell. *P < .05,
**P < .005, and ***P < .0005.
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FIG 5. ORMDL3 overexpression in airway epithelial cells enhances AHR. A, Experimental plan. B, GFP
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(Fig 3, F).
Thus, analysis of Ormdl3 KOMer mice reveal that lack of
ORMDL3 protects against the development of fungal allergen–
induced AHR, even though the mice are able to mount a robust
TH2 response in the lung and periphery.Ormdl3 KO mice have reduced cellular stress
responses to Alternaria
In vitro and in vivo studies have suggested that ORMDL3 facil-
itates the UPR.5,9,14 Therefore, to further investigate howOrmdl3deficiency, which does not affect type 2 immune responses in
response to chronic Alternaria exposure, results in protection
from allergen-induced AHR, the UPR was assessed. We specif-
ically examined whether Alternaria promotes ER stress, and
consequently UPR signaling in the lung, and more importantly,
whether the magnitude of this response is altered in Ormdl3 KO
mice. ER stress leads to detachment of the ER chaperone binding
immunoglobulin protein from the 3 key ER stress proteins PERK,
ATF6, and inositol requiring ER-to-nucleus signal kinase (IRE)-
1a, thus initiating 3 parallel pathways of the UPR signaling
cascade (Fig 4, A).11,12 IRE-1a and PERK homodimerise and
become activated following autophosphorylation of their
FIG 6. Epithelial ORMDL3 expression drives susceptibility toAlternaria-induced AHR. A,Ormdl3 expression
in epithelial (EpCam1) cells and leukocytes (CD451) sorted from WT mice. B, GFP expression (staining
green) in the lungs. C, EGFP expression in sorted epithelial cells and leukocytes from Ormdl3 KOHar mice
following administration of either AAV EGFP or AAV Ormdl3. D, Experimental plan. E, Total cells in the
BALF. F, Uric acid concentration. G-L, Lung function measured using the FlexiVent system. Airway resis-
tance (Fig 6, G and J), airway elastance (Fig 6, H and K), and airway compliance (Fig 6, I and L).M, Albumin
levels determined in BALF. Alt, Alternaria; i.n., intranasal. Representative photomicrographs are shown.
Original magnification 320. Data were collected from 2 individually performed experiments. N 5 7-12
mice per group. Box and whisker plots depict the median and interquartile range and minimum and
maximum values. *P < .05, **P < .005, and ***P < .0005.
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in the Golgi complex and subsequently translocates to the nucleus
and acts as a transcription factor.18 Activated PERK phosphory-
lates eIF2a, resulting in translational arrest of most proteins.
Treatment of mice with Alternaria resulted in phosphorylation
of eIF2a; however, generation of p-eIF2a was not modulated
by ORMDL3 (Fig 4, B). Phosphorylation of eIF2a also selec-
tively induces the transcription factor ATF4,19 which subse-
quently increases the expression of DNA-damage-inducible
transcript 3, the gene encoding CCAAT/enhancer-binding pro-
tein-homologous protein.20 Baseline expression of Atf4 mRNA
and DNA-damage-inducible transcript 3 was similar between
WTandOrmdl3KOMer mice and was not modulated by exposure
of mice to Alternaria (Fig 4, C and D).
The ATF6- and IRE-1–mediated signaling cascades result in
activation of the endoplasmic reticulum–associated protein
degradation pathway. Acting as a transcription factor, cleaved
ATF6 increases the expression of a second transcription factor X-
box binding protein 1 (Xbp1).21 Interestingly, we observed an up-
regulation of total Xbp1 mRNA expression in WT mice in
response to Alternaria (Fig 4, E). This was not observed in
Ormdl3 KOMer mice. IRE-1a splices Xbp1 mRNA21; however,
there was very little generation of the spliced Xbp1 gene product
in any of the groups (Fig 4, F), indicating that Alternaria inhala-
tion does not activate this pathway. Activation of ATF6 induces
the transcription of genes that contribute to the clearance of
unfolded/misfolded protein from the ER by binding to ER stress
response elements. ER degradation enhancer, mannosidase
alpha-like 1 (a protein degradation factor)22 is an example of an
ATF6-inducible gene and its expression was increased in
Alternaria-treated WT mice compared with PBS controls
whereas transcription of this gene in response to allergen chal-
lenge in Ormdl3 KOMer mice was significantly reduced (Fig 4,
G). The UPR is also linked to the production of several inflamma-
tory cytokines and ATF6 binds to cAMP response elements pro-
moting IL-6 mRNA transcription.23 Exposure of WT mice to
Alternaria induced a robust IL-6 response in WT mice and this
was significantly blunted in Ormdl3 KOMer mice (Fig 4, H).
In vitro and in vivo studies have demonstrated that ORMDL3
overexpression results in increased expression of another ATF6
target gene, Atap2a2, that encodes SERCA2b.5,9 However, using
Ormdl3-deficient mice we show that ORMDL3 is not an absolute
requirement for the expression of SERCA2b because basal and
Alternaria-induced SERCA2b levels were not significantly
different between WT and Ormdl3 KOMer mice (Fig 4, I). Thus,
although the UPR is not affected by the absence of ORMDL3 un-
der homeostatic conditions, ATF6 signaling as indicated by
increased expression of ER degradation enhancer, mannosidase
alpha-like 1 and IL-6 is significantly impaired in pathological
conditions where ER stress is induced by exposure to Alternaria.
Thus, the data indicate that ORMDL3 is involved in the regulation
of key genes and proteins induced by ATF6 during ER stress.
There is also a UPR-independent branch of the ER stress
response that regulates activation of the NLRP3 inflammasome.24
Alternaria exposure resulted in increased release of the damage-
associated molecular pattern, uric acid. Concomitant with the
reduced UPR in Ormdl3 KOMer mice, ORMDL3 deficiency also
protected against UPR-independent cellular stress as evidenced
by the significant reduction in uric acid released in these mice
compared with WT animals (Fig 4, J). ORMDL3 specifically af-
fects the ER stress pathway since levels of lactate dehydrogenaserelease from cells, a marker of nonspecific cellular damage,
although a modest increase in response to Alternaria was not
modulated by lack of ORMDL3 (Fig 4, K). Concurrent with the
decrease in allergen-induced uric acid levels, the Ormdl3 KOMer
mice also had significantly lower levels of bronchoalveolar lavage
fluid (BALF) albumin following Alternaria challenge. This is
indicative of maintained epithelial integrity and barrier function
in Ormdl3 KOMer mice compared with WT animals (Fig 4, L).
Further studies are needed to determine whether induction of
cellular stress is an association or causally related to induction
of AHR.Overexpression of ORMDL3 promotes allergen-
induced AHR
We next investigated the effect of overexpression of ORMDL3
in the lung using an AAV. Comparative experiments using
different AAV serotypes (1, 2, 5, 6, 7, 8, 9, and rh10) encoding
themarker geneEGFPwere conducted. These revealed that intra-
nasal treatment of neonatal mice in the first week of life with
AAV9, in combination with neuraminidase to reveal galactose
residues on the apical surface of conducting airway epithelial
cells to increase AAV9 binding,25 resulted in optimal levels of
EGFP expression in the lung (data not shown). Because of the
lack of available ORMDL3-specific antibodies to track expres-
sion, an Ormdl3-EGFP gene fusion was introduced into the
plasmid pZac2.1 to generate an AAV9 Ormdl3-EGFP virus
(AAV Ormdl3). Five-day-old Balb/c mice were treated with
vehicle (PBS), AAV EGFP, or AAV Ormdl3. At age 8 weeks,
(adult) mice were exposed to Alternaria for 5 weeks and param-
eters of AADwere assessed (Fig 5, A). A lower dose of Alternaria
was specifically chosen to determine any potential exacerbation
of disease parameters in the mice overexpressing epithelial
ORMDL3.
Treatment of neonatal micewith AAV EGFP and AAVOrmdl3
resulted in robust levels of GFP expression primarily in bronchi-
olar epithelial cells and this expression persisted into adulthood
(Fig 5, B). There was no effect of treating neonatal mice with
the control AAV EGFP vector and these animals were phenotyp-
ically indistinguishable from PBS-treated littermate controls sub-
sequently exposed to either PBS or Alternaria (Fig 5, C-G). At
homeostasis, overexpression of ORMDL3 did not affect either pa-
rameters of lung function or the inflammatory profile of the mice
(Fig 5, C-G). However, overexpression of ORMDL3 had a signif-
icant effect on Alternaria-induced AHR (Fig 5, C). At baseline
(before the MCh challenge), Alternaria-exposed AAV Ormdl3
mice had significantly higher airway resistance than did
allergen-exposed PBS or AAV EGFP-treated mice (Fig 5, D).
Airway responsiveness to MCh challenge was also increased in
the mice overexpressing ORMDL3 (Fig 5, E). In contrast, recruit-
ment of cells to the airways was not affected by ORMDL3 over-
expression (Fig 5, F and G). Alternaria-induced uric acid release
was elevated in the ORMDL3-overexpressing mice although the
increase was not statistically significant (data not shown).Epithelial-specific ORMDL3 expression restores
Alternaria-induced AAD
The previous series of experiments indicated that overexpres-
sion of ORMDL3 regulates lung function. Many of the recently
identified asthma susceptibility genes including ORMDL3 are
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pressed by epithelial (EpCam1) and hemopoietic (CD451) cells
(Fig 6, A). To assess the particular contribution of epithelial-
derived ORMDL3 expression to the generation of Alternaria-
induced pathology, we reconstituted ORMDL3 expression in
airway epithelial cells of Ormdl3 KOHar mice. Intranasal instilla-
tion of AAV Ormdl3 to neonatal mice resulted in expression
almost exclusively in bronchial epithelial cells of the conducting
airways as shown by immunofluorescence (Fig 6, B) and
confirmed by quantitative PCR of sorted epithelial (EpCam1)
and hemopoietic cells (CD451) (Fig 6, C).
At age 8 weeks, WT, KOHar, and KOHar mice expressing
ORMDL3 specifically in the airway epithelium were exposed to
Alternaria for 5 weeks and parameters of AAD were assessed
(Fig 6, D). Expression of epithelial ORMDL3 was associated
with a small but statistically significant increase in total cells in
the BALF (WT GFP PBS 6.5 3 104 vs KO Ormdl3 PBS
9.8 3 104) and uric acid (WT EGFP PBS 99 mM and KO
EGFP PBS 90 mM vs KO Ormdl3 PBS 149 mM) in the airways
but there was no other baseline phenotype in the absence of
allergen challenge (Fig 6, D and E, and Fig E2). Restoration of
epithelial ORMDL3 expression in the KOHar mice resulted in
enhanced Alternaria- induced AHR that was equal in magnitude
to that recorded in WT mice, implying that epithelial-derived
ORMDL3 governs the deleterious Alternaria-induced changes
in lung function (Fig 6, G-L). The total number of leukocytes re-
cruited to the airway lumen following Alternaria challenge was
increased in the KO mice expressing epithelial ORMDL3
compared withOrmdl3-deficient mice (Fig 6,E). Low-doseAlter-
naria revealed an effect on TH2 cells, with reduced recruitment in
Ormdl3 KOHar mice (Fig E2, A). Epithelial expression of
ORMDL3 in KOHar mice reestablished the allergen-induced in-
crease in TH2 cell accumulation (Fig E2, A). There was also a
small but significant increase in airway eosinophilia in the epithe-
lial ORMDL3-expressing KOHar mice compared with WT mice
(Fig E2, B). Congruent with the observed changes in type 2
inflammation, BALF IL-13 levels were reduced inOrmdl3KOHar
mice although the reduction was not statistically significant
(Fig E2,C). IL-13 concentrations inOrmdl3KOHar mice reconsti-
tuted with epithelial ORMDL3 were not different from those in
WT mice. There was no effect of ORMDL3 on total IgE
(Fig E2, D) or Alternaria-specific IgE levels in allergen-
exposed mice (data not shown). Levels of the cell damage marker
lactate dehydrogenase were similar in all groups of mice exposed
to allergen (Fig E2, E), congruent with our previous observations.
Viral expression of ORMDL3 inKOHar mice restored the uric acid
response to Alternaria (Fig 6, F). In response to allergen, levels of
BALF albumin were decreased in Ormdl3 KOHar mice compared
with WT mice, indicative of increased epithelial integrity (Fig 6,
M). However, in the KOHar mice reconstituted with epithelial
ORMDL3, albumin levels were equivalent to those in WT mice
(Fig 6, M). These data show that epithelial ORMDL3 governs
the cellular stress response and AHR induced by inhaled
Alternaria.DISCUSSION
GWAS have established a strong correlation between SNPs at
the 17q21 locus and the development of asthma andORMDL3 has
been proposed as an asthma susceptibility gene. However, direct
in vivo evidence for a pathophysiological function of ORMDL3 ina long-term model of AAD induced by a relevant aeroallergen
associated with human disease is lacking.
ORMDL3 expression did not influence the number of TH2 cells
or type 2 innate lymphoid cells recruited to the lung in response to
Alternaria; however, eosinophilia was reduced in mice lacking
ORMDL3. These data are in agreement with published literature
demonstrating that ORMDL3 regulates eosinophil trafficking,
recruitment, and degranulation.17 However, in our lower dose Al-
ternaria exposure regime used in the epithelial ORMDL3 recon-
stitution experiments (Fig 6), we show that the total number of
inflammatory cells recruited to the airway lumen are increased
in mice expressing epithelial ORMDL3 compared with the global
KO animals. The increased BAL cellularity was due to increased
numbers of TH2 cells and eosinophils, indicating that epithelial
ORMDL3 facilitates the trafficking of these cells to the airway
lumen. However, the ORMDL3-dependent element of allergen-
induced inflammation is overcome with higher doses of Alterna-
ria. Levels of total IgE were unaffected by the loss of ORMDL3,
indicating that ORMDL3 primarily affects innate rather than
adaptive immunity in the generation of AAD.
Our data show that Ormdl3 KO mice are protected from the
development of increased airway resistance, a function of smooth
muscle contractility, following prolonged Alternaria exposure,
implying that ORMDL3 is a critical driver of this aspect of
AHR. Interestingly, although ORMDL3 is pivotal for the genera-
tion of Alternaria- induced AHR, the same phenotype was not
observed in response to the aeroallergen house dust mite (data
not shown). Ormdl3 KO mice develop AAD when exposed to
house dust mite and the magnitude of AHR is equivalent to
allergen-treated WTmice. This suggests that ORMDL3 mediates
an Alternaria-specific activation of AAD. Sensitization to Alter-
naria has been implicated in severe asthma risk and fungal expo-
sure is known to be associated with an increase in life-threatening
exacerbations of the disease.26,27 Intriguingly, SNPs in the chro-
mosome 17q21 region in addition to being reproducibly associ-
ated with asthma have been linked to asthma exacerbations
requiring hospitalization and/or oral steroids.28,29
Mice globally overexpressing ORMDL3 have previously been
shown to have elevated levels of SERCA2b, which transports
calcium from the cytosol to the ER.5,9 However, expression of
SERCA2b is not solely dependent on the presence of ORMDL3
because levels were not altered in Ormdl3-deficient mice.
ORMDL3 has also been shown to inhibit the activity of SERCA2b
and this modulatory effect is suggested to result from direct asso-
ciation of the 2 proteins.14 The reduced sensitivity of the smooth
muscle from Ormdl3 KO mice to pharmacologically induced
contraction may therefore be due to decreased intracellular cal-
cium concentrations as a result of increased SERCA2b-mediated
uptake to the ER in the absence of ORMDL3, and reduced activity
of SERCA in airway smooth muscle is thought to contribute to
airway remodeling in those with moderate/severe asthma.30
ORMDL3, which has been shown to be induced by Alternaria,
also regulates ceramide biosynthesis, and high-level expression
of ORMDL3 increases ceramide production.8 Allergen induces
elevated ceramide levels with concomitant AHR, which is ablated
in mice treated with the sphingosine analogue FTY 720, which re-
duces both ORMDL3 and ceramide levels.8 Thus, the reduced
smooth muscle contractility measured in Ormdl3 KO mice may
also result from dysregulated lipid homeostasis.
We show that ORMDL3 expression specifically in bronchiolar
epithelial cells restores the Alternaria-induced increase in AHR,
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airway smooth muscle, it can also act indirectly. Uric acid levels
are increased in patients with asthma following segmental allergen
challenge and treatment ofHDM-challengedmicewith uricase ab-
lates allergen-induced AHR.31 We have shown that Alternaria-
induced secretion of uric acid into the airways is blunted inOrmdl3
KO mice. Conversely, viral-mediated expression of ORMDL3 in
airway epithelial cells ofKOmice reinstated the uric acid response
to allergen challenge, clearly demonstrating the importance of
epithelial-derived ORMDL3 in mediating Alternaria-induced
release of damage-associated molecular patterns. Interestingly,
uric acid is released early in the immune response to protease aller-
gens,32 and levels can be used as a biomarker for the severity of
asthma exacerbations in patients.33 Epithelial cells have an active
uric acid transport system, and basal secretion of uric acid by hu-
man airway epithelial cells has been demonstrated.34 Uric acid is
known to have direct effects on smooth muscle cells including
stimulating endothelin-1 expression and increased intracellular
calcium concentrations, which can induce smoothmuscle contrac-
tion.35,36 Thus, epithelial-expressed ORMDL3 can modulate lung
function via its effects on uric acid release induced by allergen
inhalation.
Many of the recently identified asthma susceptibility genes,
including ORMDL3, are known to be expressed in epithelial
cells,3,5 and disrupted airway epithelial barrier function is thought
to be a critical controller of disease induction.2 UsingOrmdl3KO
mice, we can infer that this protein has a vital role in the epithelial
response to allergen and dysregulated expression of ORMDL3
likely contributes to a reduction in epithelial integrity as demon-
strated by the increase in bronchoalveolar lavage albumin levels
in ORMDL3-sufficient mice compared with KO animals. In KO
mice expressing epithelial ORMDL3, Alternaria-induced in-
creases in luminal albumin were restored, suggesting that epithe-
lial ORMDL3 governs allergen-induced loss of epithelial
integrity.
Another branch of the ER stress response is the UPR. The
protein sensors PERK, IRE-1a, and ATF6 respond to ER stress by
increasing the expression of proteins such as binding immuno-
globulin protein and CCAAT/enhancer-binding protein-homolo-
gous protein,37 which have been shown to be elevated in patients
with asthma and in a murine model of neutrophilic, steroid-
resistant AAD induced by LPS/ovalbumin. These markers are
positively correlated with AHR and therapeutic treatment of
mice with 4-phenylbutyric acid, a potent ER stress inhibitor,
has been shown to reduce AHR, implying that activation of the
UPR, which is dependent on ORMDL3, is intimately linked
with lung function. In the lung, ORMDL3 activates the UPR
via the ATF6 pathway, increasing transcription of endoplasmic
reticulum–associated protein degradation pathway-specific genes
(Edem-1) and regulating the expression of IL-6, which has been
implicated in the pathogenesis of asthma.13
It is not known how the levels of ORMDL3 expression
achieved byAAV-mediated gene transfer to the airway epithelium
compare with the in vivo levels inWTmice due to the lack of spe-
cific reagents to differentiate between ORMDL1, 2, and 3 iso-
forms because of the high level of homology between these
proteins, which we have shown directly using KO mice. Despite
this, the data clearly demonstrate that epithelial ORMDL3 is
essential for the generation of AAD and GWAS indicate that
only the ORMDL3 isoform is associated with asthmasusceptibility. ORMDL3 has a cAMP response element (CRE)
in the promoter region and protein kinase A–dependent cAMP
response element binding protein phosphorylation results in bind-
ing to the cAMP response element and initiation of ORMDL3
transcription.38 ORMDL3 activates ATF6, increasing the tran-
scription of cAMP response element responsive genes; thus,
ORMDL3maymediate its own expressionvia a positive feedback
loop. In addition, Alternariol, a mycotoxin of Alternaria, in-
creases cAMP response element binding protein binding to
CREs39 and this may be the mechanism by which Alternaria in-
creases ORMDL3 expression.
Specific clinical asthma phenotypes (recurrent severe exacer-
bations) have previously been shown to be associated with
distinct genotypes (cadherin regulated familymember 3, locus).40
Stratifying patients with severe asthma into 2 groups on the basis
of their response to fungal exposure reveals that the patients who
respond to fungal allergens have earlier onset symptoms and
require more oral steroid therapy than do those who do not and
experience a greater number of asthma exacerbations.41-43
GWAS data predict that elevated ORMDL3 expression increases
the risk of severe asthma and asthma exacerbations; thus, given
the association between ORMDL3 and Alternaria-induced
AHR revealed in the present study, it would be pertinent to deter-
mine whether SNPs in the 17q21 locus are associated with severe
fungal-associated asthma phenotypes. With the current emphasis
on personalized medicine, confirmation of the mechanisms and
therapeutic targets in these specific patients could offer tailored
treatments for this group of patients with asthma who frequently
present with severe disease and are resistant to current steroid
treatments. The ER stress inhibitor sodium phenylbutyrate (4-
phenylbutyric acid) is licensed for oral administration and used
therapeutically in the management of inherited urea cycle disor-
ders.44 Because of its additional chaperone function it would be
of interest to determine whether this drug also has efficacy in pa-
tients with asthma carrying genetic variations in the ORMDL3
locus.
In conclusion, ORMDL3 is a crucial regulator of smooth
muscle contractility and subsequent AHR, acting potentially via
cellular stress pathways, the UPR, and uric acid release.
Modulation of cellular stress may represent a novel therapeutic
avenue for the treatment of asthma.We thank Lorraine Lawrence for conducting histological sectioning and
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Key messages
d In response to fungal exposure, Ormdl3 mediates the
ATF6-dependent pathway of the UPR and uric acid
release.
d The cellular stress promoted by Ormdl3 orchestrates
AHR during allergic immune responses.
d Epithelial ORMDL3 is crucial for the induction of airway
resistance.
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RT-PCR
Lung tissue samples were homogenized in TRIzol solution (Life Technol-
ogies, Warrington, UK) followed by addition of chloroform to extract nucleic
acids. RNA was isolated using the RNeasy Mini Kit (Qiagen, Manchester,
UK), including an on-column DNase digest with an RNase-free DNase set
(Qiagen) as permanufacturer’s instructions. cDNAwas amplifiedwith random
primers and the High-Capacity cDNA Reverse Transcription Kit (Life
Technologies) according to the manufacturer’s instructions.
Real-time RT-PCR reactions were performed on a ViiA 7 Real-time PCR
System (Life Technologies) in conjunction with TaqMan Fast Advanced
Master Mix (Life Technologies) and following TaqMan Gene Expression
Assays (Life Technologies): Atf4 (Mm00515325_g1), DNA-damage-
inducible transcript 3 (Mm01135937_g1), ER degradation enhancer,
mannosidase alpha-like 1 (Mm00551797_m1), Xbp1 (Mm00457357_m1),
Gapdh (Mm99999915_g1), and Hprt (Mm01545399_m1). Expression of
each target genewas normalized to the arithmetic mean of the 2 housekeeping
genes Gapdh and Hprt. Data were then expressed as fold-change of relative
mRNA expression in experimental groups versus naive WT animals.
Xbp-1 and spliced Xbp-1 (Xbp-1s) transcripts were amplified by PCR
(forward primer: ACACGCTTGGGAATGGACAC; reverse primer: CCATG
GGAAGATGTTCTGGG). The products were separated using a 4% agarose
gel (Ultrapure agarose; Invitrogen, Waltham, Mass).
Isolation and sorting of CD451 EpCam2 and CD452
EpCam1 cells
Airway epithelial cells were sorted as previously reported,E1 with minor
amendments. Lungs were perfused with ice-cold PBS through the right
cardiac ventricle. Dissociation solution (1.5 mL) (Dulbecco modified
Eagle medium/F12 [no phenol red; Life Technologies]) substituted with
25 mM HEPES (Sigma-Aldrich, Dorset, UK), penicillin/streptomycin, and
5 mg/mL dispase II (Sigma-Aldrich) was injected into the lungs through the
trachea using a 1-mL syringe, followed by 0.5 mL of 1% low gelling
temperature agarose (Sigma-Aldrich). The trachea was consequently closed
using a hemostat and the chest was cooled down with ice to facilitate agarose
solidification. The lung lobes were then harvested and incubated at 378C for
1 hour in 5-mL dissociation solution under slight agitation. The digested
tissue was passed through a 100-mm cell strainer (BD, Oxford, UK), cells
were precipitated by centrifugation, washed through a 100-mm cell
strainer for a second time to remove any remaining, solidified agarose, and
incubated at room temperature for 10 minutes in Dulbecco modified Eagle
medium/F12/25 mM HEPES in the presence of 50 mg/mL DNase I (Roche,
Welwyn Garden City, UK). Erythrocytes were lysed and the cell suspension
was extracellularly stained in sorting buffer (1% BSA in PBS) with
phycoerythrin-conjugated EpCam (eBioscience, Cheshire, UK) and Brilliant
Violet 421–conjugated CD45 (Biolegend) antimouse antibodies and sorted
using a BD FACSAria III cell sorter. QIAshredder and RNeasy micro kits
(Qiagen) were used in combination to isolate RNA. cDNAwas prepared using
the SuperScript VILO Master Mix (ThermoFisher, Waltham, Mass).
RNA/cDNA preparation steps were performed according to manufacturers’
instructions. Transcript levels of EGFP were assessed by quantitative
RT-PCR using EGFP-targeting Taqman gene expression assays
(Mr04329676_mr; Thermo Fisher). Gapdh served as the reference gene.
Immunofluorescence
Paraffin sections were stained sequentially with rabbit anti-GFP antibody
(Abcam, Cambridge, UK), biotinylated goat anti-rabbit (Jackson, Suffolk,
UK), and streptavidin AlexaFluor488 (Molecular probes, Invitrogen). Tissue
sections were visualized and images overlayed using a LeicaDM2500
microscope and QWin software (Leica Microsystems [UK] Ltd, Milton
Keynes, UK).
Western blot
Lung tissue was homogenized at 50 mg/mL tissue in RIPA buffer (Sigma,
Dorset, UK) followed by centrifugation at 13,000 rpm for 10 minutes at 48C.The resultant supernatant was used for Western blot. Proteins were
separated by SDS-PAGE and transferred to polyvinylidene difluoride
membranes. Membranes were blocked with 5% (w/v) nonfat milk in
TRIS-buffered saline with 0.05% tween-20. The following primary
antibodies were used: rabbit monoclonal anti-SERCA2 (Abcam), rabbit
polyclonal anti-GAPDH (Millipore, Watford, UK), rabbit polyclonal
anti-GAPDH Phospho-eIF2a (Ser51) (Cell Signaling Technology, Leiden,
The Netherlands), and rabbit monoclonal anti-alpha tubulin antibody
(Abcam).
Flow cytometry
BALF recovery, lung tissue digest, cell counting, and differential cell
counting were performed as described previously.E2
Single-cell suspensions from lung tissue and bronchoalveolar lavage
were stimulated with 40 ng/mL PMA (Sigma-Aldrich) and 3 mg/mL
ionomycin (MERCK Millipore, Watford, UK) in RPMI/10% FCS
containing 10 mg/mL Brefeldin A (Sigma-Aldrich) at 378C, 0.5% CO2
for 3 hours. Cells were then washed and incubated for 20 minutes at
room temperature with 10 mL normal rabbit serum (Sigma-Aldrich).
After washing, cells were stained for extracellular antigens in 5%
FCS/1% BSA in PBS for 30 minutes at 48C. Cells were then washed,
fixed, and permeabilized using Fix/Perm kit (eBioscience, Hatfield,
UK) before being stained for intracellular antigens. All antibodies
were purchased from eBioscience except anti-ICOS (Biolegend, London,
UK). Acquisition was performed using Fortessa (BD) and analysis with
FlowJo software (Flowjo, Ashland, Ala).
Mediator analysis
Lung tissue was homogenized in HBSS (Life Technologies) containing
protease inhibitor cocktail (Roche). Lung tissue supernatant, bronchoal-
veolar lavage, and serum were analyzed by ELISA; IL-4 and IL-5 (BD
PharMingen, Oxford, UK), IL-13 (Mouse Quantikine Kit [R&D Systems,
Abingdon, UK]), IL-33 (Mouse IL-33 DuoSet ELISA, R&D Systems), and
albumin (Bethyl Laboratories Inc, Montgomery, Tex). Paired antibodies for
IgE (R&D Systems) were used to measure serum immunoglobulin levels.
For determination of Alternaria-specific IgE levels, high-binding
ELISA plates were coated with 50 mg/mL Alternaria extract. Uric
acid levels were determined by Amplex Red uric acid assay (Life
Technologies) and lactate dehydrogenase levels by a lactate dehydroge-
nase–based, in vitro toxicology assay kit (Sigma-Aldrich), according to
the manufacturers’ instructions.
In vitro measurement of airway smooth muscle
function
Tracheal tissue was harvested fromWTorOrmdl3KOMer mice and bathed
in Kreb’s Henseleit solution warmed to 378C and aerated with 95% O2/5%
CO2. The tracheas were then cleared of extraneous tissue and split into 2 rings
by cutting along the transverse plane. Tissues were then sutured to
force-displacement transducers and placed in tissue baths. Following time
to stabilize, tissues were challenged with acetylcholine (1 mM) 3 times to
confirm viability and to standardize responses. Cumulative concentration-
response curves (10 nM-1 mM) were then generated to methacholine or
vehicle (Kreb’s Henseleit solution). Agonist concentration-response curves
were subsequently fitted by least-squares, nonlinear regression based on the
Hill equation (Prism 5, GraphPad Software Inc). Mean EC50 values were
calculated by averaging data from interpolation of response curves
constructed for each individual tissue within a data set.
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FIG E1. Comparative schematic of strategies used to generate Ormdl3MER KO and Ormdl3HAR KO mice. A,
Strategy used by MERCK. The gene Ormdl3 contains 4 exons of which exons 2 to 4 are encoding the
ORMDL3 protein. Exons 2 to 4 were consequently flanked by 2 antibiotic selection cassettes (Puro, puromy-
cin; Neo, neomycin) and loxP recombination sites were inserted upstream of the Puro cassette and down-
stream of the Neo cassette. Following homologous recombination, Flp recombination, and Cre
recombination steps, the resulting Ormdl3MER KO strain retains a loxP recombination site downstream of
exon 1. B, The approach used by MRC Harwell slightly differed from the MERCK strategy, as a single
neomycin selection cassette was included in the targeting vector. LoxP recombination sites were located
between exons 1 and 2 and between exon 4 and the FRT-flanked Neo cassette. The resulting Ormdl3HAR
KO mice strain therefore retains a loxP, as well as an FRT recombination site after homologous, Flp and
Cre recombination. CDS, Coding sequence; UTR, untranslated region.
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FIG E2. Effect of epithelial ORMDL3 expression on type 2 inflammation. A, TH2 cells (IL-13
1 CD41 CD31) in
the BALF. B, Eosinophils expressed as the percentage SiglecF1 CD11c2 CD682 in the BALF. C, IL-13 levels in
the BALF. Serum IgE levels (D) and lactate dehydrogenase levels (E) in the BALF. Alt, Alternaria. Data were
combined from 2 individually performed experiments. N 5 7-12 mice per group. Box and whisker plots de-
pict the median and interquartile range and minimum and maximum values. *P < .05, **P < .005, and
***P < .0005.
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